Citation Impact
Citing Papers
De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination
2003 StandoutNobel
Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells
2010
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
2016
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17β-estradiol-induced increases in rat uterine epidermal growth factor receptor binding activity and gene expression
1990
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium
1992
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
1995
Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells
1990
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Hypoxia and Inflammation
2011 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Modulation of mouse estrogen receptor transcription activity by protein kinase C delta
1998
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
The Human Transcription Factors
2018 Standout
Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
1990 Standout
BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells
2006
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner
2012
The Human Estrogen Receptor-α Is a Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and Selective Estrogen Receptor Modulators
2001
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
2010
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
A mediator required for activation of RNA polymerase II transcription in vitro
1991 StandoutNatureNobel
Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling
2010
Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction
1990 Standout
Stromal Cell-Derived Factor 1, a Novel Target of Estrogen Receptor Action, Mediates the Mitogenic Effects of Estradiol in Ovarian and Breast Cancer Cells
2003
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Genome-wide analysis of estrogen receptor binding sites
2006
Localization of Progesterone Receptor with Monoclonal Antibodies to the Human Progestin Receptor*
1988
Expansion of the eukaryotic proteome by alternative splicing
2010 StandoutNature
Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway
2000
NF-κB and cancer — identifying targets and mechanisms
2008
The Lysyl Oxidase Pro-peptide Attenuates Fibronectin-mediated Activation of Focal Adhesion Kinase and p130Cas in Breast Cancer Cells
2008
Inflammation and cancer: back to Virchow?
2001 Standout
Molecular portraits of human breast tumours
2000 StandoutNature
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Lysosomes and autophagy in cell death control
2005
GATA-3 is expressed in association with estrogen receptor in breast cancer
1999
Two Separate Mechanisms for Ligand-Independent Activation of the Estrogen Receptor
1997
Identification of phosphorylation sites in the mouse oestrogen receptor
1995
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
2004
The PI3K Pathway in Human Disease
2017 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Steroid hormone receptors compete for factors that mediate their enhancer function
1989
Determinants for the repression of estrogen receptor transcriptional activity by ligand-occupied progestin receptors
1997
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
The Crystal Structure of Yeast Fatty Acid Synthase, a Cellular Machine with Eight Active Sites Working Together
2007 StandoutNobel
A novel mediator between activator proteins and the RNA polymerase II transcription apparatus
1990 StandoutNobel
Mechanisms of normal and malignant breast epithelial growth regulation
1989
Gene regulation by steroid hormones
1989 Standout
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
2008 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Clues from cell metabolism
2010 StandoutNatureNobel
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1.
1988 StandoutNobel
The Steroid and Thyroid Hormone Receptor Superfamily
1988 StandoutScience
The Estrogen Receptor Enhances AP-1 Activity by Two Distinct Mechanisms with Different Requirements for Receptor Transactivation Functions
1999
Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.
1999
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Characterization of tissue-specific transcription by the human synapsin I gene promoter.
1991 StandoutNobel
Mechanisms of Estrogen Action
2001 Standout
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
2006
FOSL1 Inhibits Type I Interferon Responses to Malaria and Viral Infections by Blocking TBK1 and TRAF3/TRIF Interactions
2017
42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter
1987 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Growth Factors and Cancer
1991 StandoutScience
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
2013
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Fibulin-1C and Fibulin-1D splice variants have distinct functions and assemble in a hemicentin-dependent manner
2005
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Human vascular smooth muscle cells contain functional estrogen receptor.
1994
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
1995 StandoutScience
Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands
1998
Mechanisms of TGFβ-Induced Epithelial–Mesenchymal Transition
2016
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 StandoutScience
Fatty Acid Synthase and Cancer: New Application of an Old Pathway
2006
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region.
1987
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
2005 StandoutScience
Expression of an Estrogen Receptor by Human Coronary Artery and Umbilical Vein Endothelial Cells
1996
Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene.
1987 StandoutNobel
The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction.
1986
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
2003
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of Dany Chalbos being referenced
Epithelial-to-Mesenchymal Transition Induced by TGF-β1 Is Mediated by Blimp-1–Dependent Repression of BMP-5
2012
Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells
2002
Regulation of Fatty Acid Synthetase Ribonucleic Acid in the Human Endometrium during the Menstrual Cycle*
1990
Receptor-Interacting Protein 140 Binds c-Jun and Inhibits Estradiol-Induced Activator Protein-1 Activity by Reversing Glucocorticoid Receptor-Interacting Protein 1 Effect
2003
Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis
2006
Progestin Increases Gene Transcription and Messenger Ribonucleic Acid Stability of Fatty Acid Synthetase in Breast Cancer Cells
1989
Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells
2001
Progestins and androgens stimulate lipid accumulation in T47D breast cancer cells via their own receptors
1989
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2
2007
FRA-1 Expression Level Modulates Regulation of Activator Protein-1 Activity by Estradiol in Breast Cancer Cells
1998
FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells
2004
Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues.
1994
Effect of estrogen in breast cancer cells in culture: released proteins and control of cell proliferation.
1984
Estrogens Stimulate Cell Proliferation and Induce Secretory Proteins in a Human Breast Cancer Cell Line (T47D)*
1982
Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis
1993
Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells.
1987
Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells.
1984
Steroidal and non steroidal antiestrogens in breast cancer cells in culture
1984
Ubiquitin-Independent Proteasomal Degradation of Fra-1 Is Antagonized by Erk1/2 Pathway-Mediated Phosphorylation of a Unique C-Terminal Destabilizer
2007
Progestin-specific markers in human cell lines: biological and pharmacological applications
1984
Regulation of fatty acid synthetase by progesterone in normal and tumoral human mammary glands.
1990
Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription.
1994
Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'- monophosphate in MCF7 cells
1993
Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
1993